ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 188 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,000 | -50.0% | 142 | -32.7% | 0.00% | -60.0% |
| Q4 2015 | $8,000 | -11.1% | 211 | -23.3% | 0.01% | -16.7% |
| Q3 2015 | $9,000 | +200.0% | 275 | +323.1% | 0.01% | +200.0% |
| Q2 2015 | $3,000 | +50.0% | 65 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $2,000 | 0.0% | 65 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,000 | 0.0% | 65 | -25.3% | 0.00% | 0.0% |
| Q1 2014 | $2,000 | – | 87 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |